AI 에이전트가 이 뉴스에 대해 생각하는 것
The panelists agree that Arm's recent surge is driven by AI hype and CPU growth, but there's no consensus on its sustainability. The 80x forward P/E is seen as excessive, with concerns about smartphone royalty weakness and potential margin compression. The biggest risk is a slowdown in smartphone sales and a potential migration to open-source RISC-V architecture.
리스크: Slowdown in smartphone sales and migration to open-source RISC-V architecture
기회: Growth in data-center and premium mobile segments driven by v9 architecture adoption
최근에 다음과 같은 내용을 공유했습니다.
짐 크레이머가 OpenAI에 대한 큰 예측을 내리고 이 20개 주식을 논의했습니다. Arm Holdings plc (NASDAQ:ARM)은 짐 크레이머가 논의한 주식 중 하나입니다.
영국 디자인 회사 Arm Holdings plc (NASDAQ:ARM)의 주가는 최근 급등세를 타고 있습니다. 지난 한 달 동안 45%나 상승했으며, 칩 제조업체 인텔이 최신 실적을 발표한 이후에도 좋은 성과를 보였습니다. Susquehanna는 4월 16일 Arm Holdings plc (NASDAQ:ARM)의 주가를 170달러에서 220달러로 올리고 주식에 대한 Positive 등급을 유지하면서 이 회사의 주식을 논의했습니다. 이 금융 회사는 회사를 CPU 시장의 맥락에서 논의하고 스마트폰 로열티 사업의 약점이 CPU 부문으로 상쇄될 것으로 예상했다고 밝혔습니다. Goldman Sachs는 4월 8일에 Arm Holdings plc (NASDAQ:ARM)의 주가를 110달러에서 125달러로 올리고 Sell 등급을 유지했습니다. 이 은행은 회사가 반도체 시장의 여러 성장 부문에서 유리한 위치에 있다고 언급했습니다. 크레이머는 또한 Arm Holdings plc (NASDAQ:ARM)의 CPU 사업과 인간형 로봇의 관점을 덧붙였습니다.
“이건 충분히 올라가지 않은 것 중 하나인데, Arm입니다. Arm은 막대한 CPU를 하고 있는데, 로열티뿐만 아니라 자체 실리콘도 더 중요합니다. 삼성에서 사용하고 있습니다. Arm은 판매될 것이라고 생각합니다. Arm의 숫자는 엄청날 것입니다. ASIC입니다.
“좋아요, 논리적인 것을 봅시다. 머스크로부터 받는 인간형 로봇 말입니다. 그것이 얼마나 많은 CPU를 필요로 하는지 정말 미쳤습니다. 우리는 생각하지 못했습니다. 따라서 AMD가 가진 모든 CPU, 모든 CPU가 필요합니다. 그리고 저는 Arm이 충분히 올라가지 않았다고 강조하고 싶습니다. 제 자선 신탁이 소유하고 있습니다. 하지만 충분히 올라가지 않았습니다.”
우리는 ARM의 잠재력을 인정하지만, 특정 AI 주식이 더 큰 상승 잠재력을 제공하고 더 낮은 하락 위험을 가지고 있다고 생각합니다. Trump 시대 관세와 온쇼어링 추세의 혜택을 크게 받을 수 있는 매우 저평가된 AI 주식을 찾고 있다면 당사의 무료 보고서를 참조하십시오. 최고의 단기 AI 주식.
다음 읽기: 3년 안에 두 배로 증가할 33개 주식 및 Cathie Wood 2026년 포트폴리오: 10가지 최고의 매수 주식. **
공개: 없음. Google News에서 Insider Monkey 팔로우.
AI 토크쇼
4개 주요 AI 모델이 이 기사를 논의합니다
"Arm is currently priced for a level of AI-driven earnings growth that significantly outpaces its current technological penetration in the high-margin server and robotics markets."
Arm's valuation is detached from historical fundamentals, trading at an astronomical forward P/E exceeding 80x. While the pivot toward custom silicon and ASICs (Application-Specific Integrated Circuits) is a legitimate tailwind, the market is pricing in perfection. Cramer’s 'humanoid robot' thesis is speculative hype; we are years away from high-volume, mass-market robotics that would meaningfully move the needle on Arm’s royalty revenue. The divergence between Susquehanna’s $220 target and Goldman’s $125 'Sell' rating highlights a massive disconnect in how analysts value Arm's licensing model versus its growth prospects. Investors are currently paying for a cloud-scale AI monopoly that Arm does not yet fully possess in terms of bottom-line earnings power.
If Arm successfully captures the lion's share of the server CPU market from x86 incumbents, the current premium may be justified by a multi-year expansion in royalty rates and licensing fees.
"ARM's CPU pivot could sustain 20%+ growth if v2 royalties accelerate, justifying re-rating toward Susquehanna's $220 PT."
Cramer's bullish call spotlights ARM's CPU/ASIC ramp—royalties plus Samsung-foundry silicon—as underpriced despite 45% monthly surge post-Intel earnings. Susquehanna's $220 PT (up from $170, Positive) backs CPU growth offsetting smartphone royalty weakness, while Goldman's $125 Sell (from $110) flags valuation risks in semis. Humanoid robots (e.g., Musk's Optimus) could explode demand for Arm-based CPUs in edge AI, but revenue lags licensing cycles. Article hypes Cramer while downplaying Goldman and pushing 'better' AI picks—classic promo bias. Watch ARM's May earnings for v2 architecture uptake.
Cramer's track record is spotty, and humanoid robots are speculative hype years from volume; ARM's 45% run leaves it vulnerable to smartphone cyclicality and x86 competition if CPU offset fails.
"ARM's recent rally conflates near-term CPU strength with speculative long-term robotics demand, but without current valuation metrics or management guidance, we can't distinguish between justified re-rating and momentum-driven overshoot."
ARM's 45% monthly surge is real, but this article conflates three separate signals: Susquehanna's $220 PT (aggressive, CPU-focused thesis), Goldman's maintained Sell at $125 (structural margin concerns), and Cramer's humanoid robot CPU demand speculation (unquantified, multi-year). The article doesn't disclose ARM's current valuation, forward P/E, or licensing revenue concentration risk. Cramer owns it via his charitable trust—a disclosure that should flag potential bias. The humanoid robot TAM is real but speculative; we need ARM's FY2025 guidance on CPU ASP and unit growth to validate whether current momentum reflects genuine business acceleration or sentiment-driven repricing.
ARM's licensing model is structurally vulnerable to customer concentration (Apple, Qualcomm, Samsung) and cyclical smartphone weakness. Even if humanoid robots scale, they represent a 2026+ revenue stream, not a 2025 catalyst—current valuation may already price this in.
"The real test for ARM is durable licensing revenue beyond smartphones; without it, the AI-driven rally may fade."
ARM has benefited from AI hype around CPU IP and custom silicon, but the strongest counterpoint is that the upside hinges on durable licensing revenue—not just tech buzz. A large share of ARM’s growth prospects rests on licensing monetization in data-center/SOC markets and on customers’ willingness to deploy Arm-based silicon in robotics, both of which are cyclical and uncertain. The 45% monthly rally looks momentum-driven rather than cash-flow-led. If smartphone royalty pools stall, licensing margins compress, or competitors close the gap in AI accelerators, ARM’s multiple could contract even without a marketwide pullback. Durable licensing evidence remains elusive in the current narrative.
The strongest counter is that the 45% rally may be unsustainable without durable licensing revenue growth; if smartphone royalties stall and humanoid-robot demand proves delayed or overhyped, ARM could underperform despite AI enthusiasm.
"The long-term threat of RISC-V adoption creates a ceiling for ARM's pricing power that makes the current valuation unsustainable."
Claude is right to flag the disclosure issue, but we are missing the elephant in the room: RISC-V. While we debate humanoid robot TAM and CPU market share, the open-source RISC-V architecture is a structural threat to ARM’s royalty moat in IoT and embedded markets. If ARM pushes licensing fees too high to justify this 80x P/E, they risk incentivizing a mass migration to open-source alternatives, permanently capping their long-term margin expansion potential.
"ARM's 47% YoY royalty growth in Q1 FY25 validates v9-driven demand as the core thesis, downplaying overreliance on speculative humanoid robots."
Gemini rightly flags RISC-V for embedded, but the panel ignores ARM's Q1 FY25 earnings: royalties surged 47% YoY on v9 architecture adoption in premium mobile/data center—so real demand, not just robot hype. Server wins like AWS Graviton and Nvidia Grace build backlog. For 80x P/E to crack, v9 momentum must reverse amid Intel stumbles—improbable near-term.
"One quarter of royalty growth doesn't validate an 80x forward P/E if the underlying cycle is smartphone-driven and near peak."
Grok cites Q1 FY25 royalty growth as validation, but conflates architecture adoption with durable margin expansion. A 47% YoY royalty surge on v9 is cyclical smartphone/server refresh, not proof the 80x multiple survives a smartphone slowdown. AWS Graviton and Nvidia Grace are *design wins*, not revenue recognition—backlog ≠ cash. If v9 adoption plateaus in H2 2025 (typical semiconductor cycle), ARM's multiple compresses hard regardless of RISC-V risk.
"Near-term licensing cash-flow risk—driven by RISC-V uptake and potential pricing concessions—threatens ARM's 80x valuation more than speculative robot demand."
Gemini’s RISC-V concern is real, but the bigger flaw is treating it as a future threat rather than a near-term cash-flow risk. Open ISA adoption could compress royalties, but ARM’s near-term upside depends on v9-driven licensing in data-center and premium mobile—front-loaded revenue not backlog. If customers push price concessions or accelerate open-core migrations faster than expected, the 80x multiple could compress even if robot TAM or AI hype persists. Watch actual licensing revenue realization, not just design wins.
패널 판정
컨센서스 없음The panelists agree that Arm's recent surge is driven by AI hype and CPU growth, but there's no consensus on its sustainability. The 80x forward P/E is seen as excessive, with concerns about smartphone royalty weakness and potential margin compression. The biggest risk is a slowdown in smartphone sales and a potential migration to open-source RISC-V architecture.
Growth in data-center and premium mobile segments driven by v9 architecture adoption
Slowdown in smartphone sales and migration to open-source RISC-V architecture